The SVP & Pres, Eur, Mid-East, Afr of Boston Scientific Corp (BSX) is Selling Shares


Today, the SVP & Pres, Eur, Mid-East, Afr of Boston Scientific Corp (NYSE: BSX), Thepaut Eric Francis Yves, sold shares of BSX for $603.3K.

Following Thepaut Eric Francis Yves’ last BSX Sell transaction on February 08, 2017, the stock climbed by 5.1%. In addition to Thepaut Eric Francis Yves, one other BSX executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Boston Scientific Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $2.38 billion and quarterly net profit of $298 million. In comparison, last year the company earned revenue of $2.16 billion and had a net profit of $290 million. BSX’s market cap is $41.83B and the company has a P/E ratio of 433.14. Currently, Boston Scientific Corp has an average volume of 3.81M.

Based on 10 analyst ratings, the analyst consensus is Strong Buy with an average price target of $33.40, reflecting a -8.8% downside. Three different firms, including Barclays and Goldman Sachs, currently also have a Sell rating on the stock.

The insider sentiment on Boston Scientific Corp has been negative according to 132 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts